Abstract
Food-allergic consumers encounter inadequate, confusing, and ambiguous allergen information for packaged and unpackaged foods. Key Australian and New Zealand allergy organizations convened multiple forums to facilitate discussions among consumers, food manufacturers, food retailers, regulatory bodies, researchers, and health professionals to develop a unified approach to improving food allergen management. The following stakeholder consensus statement provides a foundation for advocacy for improved food allergen management and safety. It is the responsibility of consumers to: 1. declare their food allergies and read food labels (including ingredient lists and allergen declaration statements), and 2. ultimately make their own judgment about the foods they choose to consume. We consider that to enable consumers to make informed decisions about their safety, It is the responsibility of packaged food manufacturers to: 1. follow robust allergen management practices including quantitative risk assessment, and 2. use clear, consistent labeling to inform consumers about that food's allergen content, including the possible presence of unintended allergens. It is the responsibility of food service establishments and providers to: 1. follow robust allergen management practices, and 2. ensure that staff understand and can inform consumers about the allergen content of the food they provide, including the possible presence of unintended allergens.
Original language | English |
---|---|
Journal | Journal of Allergy and Clinical Immunology: In Practice |
DOIs | |
Publication status | Accepted/In press - 2022 |
ASJC Scopus subject areas
- Immunology and Allergy
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
An International First : Stakeholder Consensus Statement for Food Allergen Management in Packaged Foods and Food Service for Australia and New Zealand. / Roche, Ingrid; Vale, Sandra L.; Hornung, Catherine J. et al.
In: Journal of Allergy and Clinical Immunology: In Practice, 2022.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - An International First
T2 - Stakeholder Consensus Statement for Food Allergen Management in Packaged Foods and Food Service for Australia and New Zealand
AU - Roche, Ingrid
AU - Vale, Sandra L.
AU - Hornung, Catherine J.
AU - Zurzolo, Giovanni A.
AU - Netting, Merryn J.
AU - Dharmage, Shyamali C.
AU - Gray, Caroline
AU - Lee, Nanju A.
AU - Lacis-Lee, Jasmine
AU - Jorgensen, Penelope F.
AU - Smith, Jill
AU - Freeman, Wendy
AU - Perrett, Kirsten P.
AU - Voukelatos, Sally
AU - McWilliam, Vicki L.
AU - Grinter, Kirsten
AU - Koplin, Jennifer J.
AU - Said, Maria
AU - Campbell, Dianne E.
N1 - Funding Information: Conflicts of interest: W. Freeman is a voluntary member of the National Allergy Strategy Steering Committee. C.J. Hornung contributed to this work through employment as the CFAR Coordinator. J. Lacis-Lee is a voluntary board director for the Allergen Bureau. K.P. Perrett received a Melbourne Children’s Clinician-Scientist Fellowship; received payments to her institution from the National Health and Medical Research Council of Australia (NHMRC) Investigator fellowship, Australia, NHMRC CTCS grant, EW Thrasher grant, United Kingdom, Allergy and Immunology Foundation of Australia, National Institutes of Health National Institute of Allergy and Infectious Diseases, United States, DBV Technologies , and Novartis; received consulting fees (paid to her institution) from Aravax; received support for attending meetings/travel (paid to her institution) from MedImmune; participated in a data safety and monitoring board/advisory board (voluntary): Concussion Essentials and Allergy Pal (chair, scientific advisory board). V.L. McWilliam received MCRI, Australia Theme Funding Grants 2021 and 2019 (research salary support); Allergy and Immunology Foundation of Australia project funding; EW Thrasher Grant project funding; received payment of speaker honoraria from Nutricia, Nestlé Health Sciences, and Abbott; and had a leadership or fiduciary role in the AusEE scientific advisory board (voluntary). C. Gray received support from the Allergen Bureau, International Flavours and Fragrances NZLtd, New Zealand, and Danisco NZLtd; received support for attending meetings/travel from DuPont NZLtd, United States; and had a leadership or fiduciary role in the Allergen Bureau Board of Directors. J. Smith had a leadership or fiduciary role as the CEO of the Australasian Society of Clinical Immunology and Allergy. M.J. Netting received NHMRC Early Career Fellowship APP1156518; Grants or contracts from the Nestlé Nutrition Institute; and payment or honoraria from the Nestlé Nutrition Institute (speaker honoraria). D.E. Campbell received grants or contracts from the NHMRC, Australia (project funding to the institution); received consulting fees from the Allergenis Advisory board (paid to herself) and from the Westmead Fertility Centre Governance Committee (paid to the institution); received payment or honoraria from Nestlé Health Sciences (paid to the institution); received support for attending meetings from the NSW Ministry of Health, Australia and DBV Technologies ; participated in a data safety monitoring board: St Vincent’s Hospital Sydney CAR T cell DSBM (voluntary); received stock or stock options from DBV Technologies (stock options); and is a part-time employee of DBV Technologies. K. Grinter declares a leadership or fiduciary role as Allergen Bureau director (voluntary). The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: The Centre for Food and Allergy Research is funded by National Health and Medical Research Council of Australia Centre for Research Excellence GNT1134812. J.J. Koplin is supported by National Health and Medical Research Council of Australia Fellowship GNT1158699. Funding Information: The Centre for Food and Allergy Research is funded by National Health and Medical Research Council of Australia Centre for Research Excellence GNT1134812. J.J. Koplin is supported by National Health and Medical Research Council of Australia Fellowship GNT1158699.Conflicts of interest: W. Freeman is a voluntary member of the National Allergy Strategy Steering Committee. C.J. Hornung contributed to this work through employment as the CFAR Coordinator. J. Lacis-Lee is a voluntary board director for the Allergen Bureau. K.P. Perrett received a Melbourne Children's Clinician-Scientist Fellowship; received payments to her institution from the National Health and Medical Research Council of Australia (NHMRC) Investigator fellowship, Australia, NHMRC CTCS grant, EW Thrasher grant, United Kingdom, Allergy and Immunology Foundation of Australia, National Institutes of Health National Institute of Allergy and Infectious Diseases, United States, DBV Technologies, and Novartis; received consulting fees (paid to her institution) from Aravax; received support for attending meetings/travel (paid to her institution) from MedImmune; participated in a data safety and monitoring board/advisory board (voluntary): Concussion Essentials and Allergy Pal (chair, scientific advisory board). V.L. McWilliam received MCRI, Australia Theme Funding Grants 2021 and 2019 (research salary support); Allergy and Immunology Foundation of Australia project funding; EW Thrasher Grant project funding; received payment of speaker honoraria from Nutricia, Nestlé Health Sciences, and Abbott; and had a leadership or fiduciary role in the AusEE scientific advisory board (voluntary). C. Gray received support from the Allergen Bureau, International Flavours and Fragrances NZLtd, New Zealand, and Danisco NZLtd; received support for attending meetings/travel from DuPont NZLtd, United States; and had a leadership or fiduciary role in the Allergen Bureau Board of Directors. J. Smith had a leadership or fiduciary role as the CEO of the Australasian Society of Clinical Immunology and Allergy. M.J. Netting received NHMRC Early Career Fellowship APP1156518; Grants or contracts from the Nestlé Nutrition Institute; and payment or honoraria from the Nestlé Nutrition Institute (speaker honoraria). D.E. Campbell received grants or contracts from the NHMRC, Australia (project funding to the institution); received consulting fees from the Allergenis Advisory board (paid to herself) and from the Westmead Fertility Centre Governance Committee (paid to the institution); received payment or honoraria from Nestlé Health Sciences (paid to the institution); received support for attending meetings from the NSW Ministry of Health, Australia and DBV Technologies; participated in a data safety monitoring board: St Vincent's Hospital Sydney CAR T cell DSBM (voluntary); received stock or stock options from DBV Technologies (stock options); and is a part-time employee of DBV Technologies. K. Grinter declares a leadership or fiduciary role as Allergen Bureau director (voluntary). The rest of the authors declare that they have no relevant conflicts of interest. Publisher Copyright: © 2022 American Academy of Allergy, Asthma & Immunology
PY - 2022
Y1 - 2022
N2 - Food-allergic consumers encounter inadequate, confusing, and ambiguous allergen information for packaged and unpackaged foods. Key Australian and New Zealand allergy organizations convened multiple forums to facilitate discussions among consumers, food manufacturers, food retailers, regulatory bodies, researchers, and health professionals to develop a unified approach to improving food allergen management. The following stakeholder consensus statement provides a foundation for advocacy for improved food allergen management and safety. It is the responsibility of consumers to: 1. declare their food allergies and read food labels (including ingredient lists and allergen declaration statements), and 2. ultimately make their own judgment about the foods they choose to consume. We consider that to enable consumers to make informed decisions about their safety, It is the responsibility of packaged food manufacturers to: 1. follow robust allergen management practices including quantitative risk assessment, and 2. use clear, consistent labeling to inform consumers about that food's allergen content, including the possible presence of unintended allergens. It is the responsibility of food service establishments and providers to: 1. follow robust allergen management practices, and 2. ensure that staff understand and can inform consumers about the allergen content of the food they provide, including the possible presence of unintended allergens.
AB - Food-allergic consumers encounter inadequate, confusing, and ambiguous allergen information for packaged and unpackaged foods. Key Australian and New Zealand allergy organizations convened multiple forums to facilitate discussions among consumers, food manufacturers, food retailers, regulatory bodies, researchers, and health professionals to develop a unified approach to improving food allergen management. The following stakeholder consensus statement provides a foundation for advocacy for improved food allergen management and safety. It is the responsibility of consumers to: 1. declare their food allergies and read food labels (including ingredient lists and allergen declaration statements), and 2. ultimately make their own judgment about the foods they choose to consume. We consider that to enable consumers to make informed decisions about their safety, It is the responsibility of packaged food manufacturers to: 1. follow robust allergen management practices including quantitative risk assessment, and 2. use clear, consistent labeling to inform consumers about that food's allergen content, including the possible presence of unintended allergens. It is the responsibility of food service establishments and providers to: 1. follow robust allergen management practices, and 2. ensure that staff understand and can inform consumers about the allergen content of the food they provide, including the possible presence of unintended allergens.
UR - http://www.scopus.com/inward/record.url?scp=85132663051&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2022.03.018
DO - 10.1016/j.jaip.2022.03.018
M3 - Article
C2 - 35381394
AN - SCOPUS:85132663051
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
ER -